Hyloris Developments
- Address
- Boulev. De Patience Et Beajonc 3 Bus 1
Sponsor Overview
Specializations
Anticoagulation and Bleeding Prevention
Research activity includes management of clinically relevant bleeding events in patients receiving direct oral anticoagulants and vitamin K antagonists, with a focus on bleeding control in the setting of tooth extraction.
- Tranexamic Acid for oral bleeding prevention
- Postoperative oral hemorrhage
- Orofacial hematomas
The therapeutic interest centers on reducing bleeding complications in dental procedures among anticoagulated patients.
Dental and Oral Surgery
Clinical research also addresses oral health and procedural hemostasis in patients undergoing single or multiple tooth extractions, where bleeding risk is a key concern.
- Oral surgery
- Extractions in anticoagulated patients
- Hemostatic support in dentistry
This area reflects interest in improving safety around minor surgical procedures performed in patients with elevated bleeding risk.
Cardiovascular Pharmacology
Another area of activity involves dofetilide, a cardiac antiarrhythmic agent, with attention to its pharmacokinetic and safety profile in healthy subjects.
- Antiarrhythmic therapy
- Cardiac rhythm management
- Systemic exposure assessment
The portfolio includes evaluation of formulations relevant to cardiovascular medicine and arrhythmia treatment.
Drug Formulation and Bioavailability
Hyloris Developments is also involved in comparative research on intravenous and oral formulations, with emphasis on bioavailability and tolerability in healthy volunteers.
- Intravenous-to-oral comparison
- Pharmacokinetic profiling
- Formulation assessment
This work supports development in specialty pharmaceuticals where route of administration and exposure characteristics are central.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Comparative Bioavailability Study of Intravenous vs. Oral Dofetilide in Healthy Subjects Under Fasting Conditions |  Bulgaria | Not Recruiting |
| Efficacy and Safety of Tranexamic Acid Oral Solution 5% in Preventing Postoperative Bleeding in Patients on Anticoagulants Undergoing Dental Extractions |  Croatia Hungary Romania Spain | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 20 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
- 2.Stomatognathic Diseases1 trial16 other sponsors
Partnered Research Centres
20 centres- Address
- Plaça del Pla del Mestre, 7, 08540 Centelles
- Address
- Avinguda de Mossen Jacint Verdaguer, 11, 08130 Santa Perpètua de la Mogoda
- Address
- Ulica Vjekoslava Klaica 16, 10000 Zagreb
- Address
- Avenija Gojka Suska 6, Zagreb, 10000 Zagreb
- Address
- C/ Feria S/N, 11591 Jerez de la Frontera
- Address
- C/Gremi Passamaners 11, 07009 Palma
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Hyloris Developments.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.